Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats - PubMed (original) (raw)
Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats
R G D'Antonio et al. Antimicrob Agents Chemother. 1986 Feb.
Abstract
Daily administration of 1 mg of folinic acid to immunosuppressed rats with incipient or established Pneumocystis carinii pneumonia did not impair the capacity of trimethoprim-sulfamethoxazole to either prevent or treat this disease. These observations constitute the first experimental support for the use of folinic acid to prevent or control cytopenias that occur in patients with Pneumocystis carinii pneumonia who are under trimethoprim-sulfamethoxazole treatment.
Similar articles
- Resistance to trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. Implication of folinic acid.
Nunn PP, Allistone JC. Nunn PP, et al. Chest. 1984 Jul;86(1):149-50. doi: 10.1378/chest.86.1.149. Chest. 1984. PMID: 6610537 - Effect of folic and folinic acid on cytopenia occurring during co-trimoxazole treatment of Pneumocystis carinii pneumonia.
Bygbjerg IC, Lund JT, Hørding M. Bygbjerg IC, et al. Scand J Infect Dis. 1988;20(6):685-6. doi: 10.3109/00365548809035671. Scand J Infect Dis. 1988. PMID: 3265540 - Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.
Hughes WT, Smith BL, Jacobus DP. Hughes WT, et al. Antimicrob Agents Chemother. 1986 Mar;29(3):509-10. doi: 10.1128/AAC.29.3.509. Antimicrob Agents Chemother. 1986. PMID: 3487287 Free PMC article. - Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Fischl MA. Fischl MA. AIDS. 1988;2 Suppl 1:S143-50. doi: 10.1097/00002030-198800001-00022. AIDS. 1988. PMID: 2976274 Review. No abstract available. - Prevention of Pneumocystis carinii pneumonia.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1988 Oct 7;30(776):94-5. Med Lett Drugs Ther. 1988. PMID: 3050408 Review. No abstract available.
Cited by
- Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.
Walzer PD, Kim CK, Foy JM, Linke MJ, Cushion MT. Walzer PD, et al. Antimicrob Agents Chemother. 1988 Jan;32(1):96-103. doi: 10.1128/AAC.32.1.96. Antimicrob Agents Chemother. 1988. PMID: 3258144 Free PMC article. - Improved rat model for studying Pneumocystis carinii pneumonia.
Bartlett MS, Queener SF, Jay MA, Durkin MM, Smith JW. Bartlett MS, et al. J Clin Microbiol. 1987 Mar;25(3):480-4. doi: 10.1128/jcm.25.3.480-484.1987. J Clin Microbiol. 1987. PMID: 2952669 Free PMC article. - Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs.
Walzer PD, Foy J, Steele P, White M. Walzer PD, et al. Antimicrob Agents Chemother. 1992 Sep;36(9):1943-50. doi: 10.1128/AAC.36.9.1943. Antimicrob Agents Chemother. 1992. PMID: 1416885 Free PMC article. Review. - Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia.
Walzer PD, Foy J, Steele P, Kim CK, White M, Klein RS, Otter BA, Allegra C. Walzer PD, et al. Antimicrob Agents Chemother. 1992 Sep;36(9):1935-42. doi: 10.1128/AAC.36.9.1935. Antimicrob Agents Chemother. 1992. PMID: 1416884 Free PMC article.
References
- Clin Pharmacol Ther. 1968 Sep-Oct;9(5):550-60 - PubMed
- Br Med J. 1971 Sep 11;3(5775):610-2 - PubMed
- Antimicrob Agents Chemother. 1974 Mar;5(3):289-93 - PubMed
- Br J Haematol. 1978 Nov;40(3):363-7 - PubMed
- Blood. 1980 Mar;55(3):501-4 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources